BackInnospec Overview

Innospec Other Current Liabilities

Track Innospec's other current liabilities ($170M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$170.60M
17160.00% YoYΔ $171.60M vs prior year quarter

Peer average

Loading

Innospec Other Current Liabilities History

Loading

Innospec vs. peers: Other Current Liabilities Comparison

Loading

Innospec Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Innospec (IOSP) FAQ

The latest other current liabilities for IOSP is $170M as of March 2026. That compares with $-1M in the prior-year period — up 17160.0% year over year. Investors often review this figure alongside Innospec's historical trend and sector peers before judging valuation or financial health.

Over the past year, IOSP's other current liabilities moved from $-1M to $170M — a 17160.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Innospec's operating scale or balance-sheet position.

A other current liabilities figure of $170M for IOSP is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IOSP's other current liabilities ($170M), review year-over-year change from $-1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Innospec's other current liabilities against similar Consumer Discretionary names. You can also browse sector and industry screens on Stockcircle for a broader set of Consumer Discretionary companies and their key multiples and fundamentals.